ResMed (RMD) Short Interest Ratio & Short Volume → Gold Mania (From Stansberry Research) (Ad) Free RMD Stock Alerts $216.98 -1.17 (-0.54%) (As of 05/3/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability ResMed Short Interest DataCurrent Short Volume7,950,000 sharesPrevious Short Volume7,890,000 sharesChange Vs. Previous Month+0.76%Dollar Volume Sold Short$1.47 billionShort Interest Ratio / Days to Cover7.5Last Record DateApril 15, 2024Outstanding Shares146,910,000 sharesPercentage of Shares Shorted5.41%Today's Trading Volume655,018 sharesAverage Trading Volume1,339,844 sharesToday's Volume Vs. Average49% Short Selling ResMed ? Sign up to receive the latest short interest report for ResMed and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRMD Short Interest Over TimeRMD Days to Cover Over TimeRMD Percentage of Float Shorted Over Time Ad Paradigm PressNever use this word on your phone (FBI could be watching)This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...Watch my unredacted video about what I think is coming next right here ResMed Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20247,950,000 shares $1.47 billion +0.8%N/A7.5 $185.09 3/31/20247,890,000 shares $1.56 billion +3.0%N/A7.8 $198.03 3/15/20247,660,000 shares $1.46 billion +13.3%N/A7.9 $190.10 2/29/20246,760,000 shares $1.17 billion +2.7%N/A7.4 $173.72 2/15/20246,580,000 shares $1.20 billion +4.0%N/A7.4 $182.64 1/31/20246,330,000 shares $1.20 billion +7.5%N/A6.5 $190.20 Get the Latest News and Ratings for RMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ResMed and its competitors with MarketBeat's FREE daily newsletter. 1/15/20245,890,000 shares $1.02 billion +3.9%N/A5.5 $173.90 12/31/20235,670,000 shares $975.35 million -2.4%N/A4.8 $172.02 12/15/20235,810,000 shares $982.18 million -0.7%N/A4.4 $169.05 11/30/20235,850,000 shares $922.72 million -7.3%N/A3.9 $157.73 11/15/20236,310,000 shares $960.07 million +10.3%N/A3.9 $152.15 10/31/20235,720,000 shares $807.78 million +18.4%N/A3.3 $141.22 10/15/20234,830,000 shares $677.41 million +1.5%N/A2.9 $140.25 9/30/20234,760,000 shares $703.86 million +24.6%N/A3.2 $147.87 9/15/20233,820,000 shares $555.39 million +20.9%N/A2.9 $145.39 8/31/20233,160,000 shares $504.30 million +110.7%N/A2.8 $159.59 8/15/20231,500,000 shares $275.03 million +19.1%N/A1.6 $183.35 7/31/20231,260,000 shares $280.16 million -5.3%N/A1.7 $222.35 7/15/20231,330,000 shares $295.73 million +11.8%N/A2.1 $222.35 6/30/20231,190,000 shares $260.02 million +15.5%N/A1.9 $218.50 6/15/20231,030,000 shares $225.42 million -28.5%N/A1.7 $218.85 5/31/20231,440,000 shares $303.54 million +38.5%N/A2.4 $210.79 5/15/20231,040,000 shares $241.79 million +2.0%N/A1.9 $232.49 4/30/20231,020,000 shares $245.78 million -11.3%N/A1.8 $240.96 4/15/20231,150,000 shares $258.24 million -19.0%N/A2 $224.56 3/31/20231,420,000 shares $310.97 million +9.2%1.0%2.3 $218.99 3/15/20231,300,000 shares $270.39 million +20.4%0.9%2 $207.99 2/28/20231,080,000 shares $230.04 million +1.9%0.7%1.7 $213.00 2/15/20231,060,000 shares $227.77 million +25.5%0.7%1.7 $214.88 1/31/2023844,900 shares $192.95 million -0.6%0.6%1.5 $228.37 1/15/2023850,000 shares $185.39 million -15.8%0.6%1.5 $218.10 12/30/20221,010,000 shares $210.21 million +6.3%0.7%1.8 $208.13 12/15/2022950,100 shares $204.31 million -5.9%0.7%1.8 $215.04 11/30/20221,010,000 shares $232.50 million -5.6%0.7%2 $230.20 11/15/20221,070,000 shares $239.28 million -18.3%0.7%2.2 $223.63 10/31/20221,310,000 shares $293.03 million +6.5%0.9%2.6 $223.69 10/15/20221,230,000 shares $260.45 million -8.2%0.9%2.6 $211.75 9/30/20221,340,000 shares $292.52 million -11.3%0.9%2.9 $218.30 9/15/20221,510,000 shares $341.18 million +18.0%1.0%3 $225.95 8/31/20221,280,000 shares $281.50 million -3.0%0.9%2.3 $219.92Automatic Income (from home) (Ad)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. Just click here now to watch my presentation for free. RMD Short Interest - Frequently Asked Questions What is ResMed's current short interest? Short interest is the volume of ResMed shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 7,950,000 shares of RMD short. Learn More on ResMed's current short interest. What is a good short interest ratio for ResMed? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RMD shares currently have a short interest ratio of 8.0. Learn More on ResMed's short interest ratio. Which institutional investors are shorting ResMed? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ResMed: Capstone Investment Advisors LLC, Concourse Financial Group Securities Inc., Caas Capital Management LP, PEAK6 Investments LLC, Pura Vida Investments LLC, Capstone Investment Advisors LLC, UBS Group AG, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is ResMed's short interest increasing or decreasing? ResMed saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 7,950,000 shares, an increase of 0.8% from the previous total of 7,890,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ResMed's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to ResMed: Baxter International Inc. (1.91%), DexCom, Inc. (2.96%), Insulet Co. (4.08%), Teleflex Incorporated (1.51%), Becton, Dickinson and Company (0.80%), Boston Scientific Co. (0.88%), West Pharmaceutical Services, Inc. (1.34%), Shockwave Medical, Inc. (3.92%), Biogen Inc. (2.26%), GE HealthCare Technologies Inc. (2.59%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short ResMed stock? Short selling RMD is an investing strategy that aims to generate trading profit from ResMed as its price is falling. RMD shares are trading down $1.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ResMed? A short squeeze for ResMed occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RMD, which in turn drives the price of the stock up even further. How often is ResMed's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RMD, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Baxter International Short Interest Data DexCom Short Interest Data Insulet Short Interest Data Teleflex Short Interest Data Becton, Dickinson and Company Short Interest Data Boston Scientific Short Interest Data West Pharmaceutical Services Short Interest Data Shockwave Medical Short Interest Data Biogen Short Interest Data GE HealthCare Technologies Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:RMD) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchStock-Picking AI Predicts #1 Stock of 2024AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlaceThe asset beating inflation by 4xColonial Metals